The oncology community faces a critical challenge regarding the inconsistent reporting of trial data. Daniel Araujo, MD, highlights a fundamental flaw in how current treatments are evaluated across different borders. There is a pressing need for a unified standard of care to ensure that patients everywhere receive equitable treatment options. Watch the full interview with Dr Araujo.Read More
Why Standardized Oncology Care is a Global Necessity | Targeted Oncology – Immunotherapy, Biomarkers, and Cancer Pathways
Related Posts
Add A Comment
